Please assess the completion status of the following clinical trial:

Trial Title: Rapip Study: Clinical Trial on Remifentanyl for Analgesia and Sedation of Ventilated Neonates and Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ventilated term newborns and infants ≤ 60 days~* Expected time of artificial ventilation between 12 and 96 hours~Exclusion Criteria:~* Neuromuscular diseases~* Drug abuse of the mother (exclusion criteria for newborns)~* Known hypersensitivity to Ultiva® or Fentanyl-Janssen®~* Missing informed consent of the parents~* Participation in another clinical trial during the last 4 weeks before start of this trial

- Gender: ALL
- Minimum Age: None
- Maximum Age: 60 Days
- Healthy Volunteers: f

Study Arms:
- 2 (Type: ACTIVE_COMPARATOR): Fentanyl
- 1 (Type: EXPERIMENTAL): Remifentanyl

Based on this trial design, predict the completion outcome and termination type (if applicable).